NCT06201000View on ClinicalTrials.gov

Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients

RecruitingOBSERVATIONAL
Enrollment

282

Participants

Timeline

Start Date

December 27, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

September 1, 2024

Conditions
Genetic PolymorphismsHeart Failure
Interventions
DRUG

SGLT2 inhibitors (Dapagliflozin and Empagliflozin)

10 mg of dapagliflozin or empagliflozin

Trial Locations (1)

32610

RECRUITING

University of Florida, Gainesville

All Listed Sponsors
collaborator

University of Florida

OTHER

collaborator

National Heart Institute, Egypt

OTHER_GOV

collaborator

Beni-Suef University

OTHER

lead

October 6 University

OTHER